Convenzione: update on the proposals received following the first level consultation
The Technical Committee (TC) as foreseen by the Convenzione signed on 30 December 2020 between the Ministry of University and Research, the Ministry of Health and the Ministry of Economy and Finance and the Human Technopole Foundation (HT) informs that 29 National Facilities were proposed by the national scientific community as part of the first level consultation, provided for by the Convenzione.
This first phase of the process, as illustrated in the attached communication by the Technical Committee, saw the involvement of 167 institutional stakeholders representing universities, research hospitals (IRCCS), research centres, funding organisations and the life science industry as identified by the Committee.
These stakeholders were invited to contribute to the identification of a first set of priority facilities in high demand by the national life sciences community. A total of 60 questionnaires were submitted, 48 with initiatives supported by several institutes and 12 from single institutes.
The 29 proposed National Facilities are currently being evaluated by the Technical Committee. Following this evaluation, a second level consultation will begin aimed at the entire scientific community and key players of society by providing them with the list of potential platforms of national interest.
Once the second level consultation will have been completed, the Technical Committee will draft a final report for Human Technopole and the involved Ministries to share the results of the consultations and the indication, in order of priority, of the Facilities in highest demand by the national scientific community.
The Convenzione of 30 December 2020, which implemented the 2020 Budget Law, further enhances HT’s efforts to create a scientific hub to support research in Italy with high level infrastructures and skills, to be built together with interested scientific communities and open on a competitive basis to all Italian researchers, independently of their institutional affiliation.
Share:
You could also like:
-
Italy at the centre of the Genome of Europe project
The Human Technopole, ELIXIR Italia, the national node of the European life sciences research infrastructure coordinated by the National Research Council (CNR), and the Centro Cardiologico Monzino, as the Italian coordinating centre, have been selected as the Italian partners of Genome of Europe (GoE), the largest EU-funded genomic project, whose ultimate goal is to make […]
-
Human Technopole wins 2024 Oscar di Bilancio
On Friday 13 December, at Palazzo Mezzanotte in Milan, the Human Technopole Foundation’s ‘Integrated Report 2023’ received the Oscar di Bilancio in the social enterprises and non-profit organisations category. The award was presented to President Gianmario Verona, Elena Trovesi, Head of Administration, as well as the project leaders Giovanni Selmi, Head of Finance, and Alessandro […]
-
Mosaic Organoids to Study the Brains of Multiple Patients Simultaneously
An international team of scientists from Human Technopole and the University of Milan has developed and validated an innovative approach to studying human brain development across multiple individuals simultaneously using single organoids—laboratory models that replicate key cellular processes of human neurodevelopment. The research paves the way for in vitro population studies. Additionally, the scientists have developed a novel computational method to more accurately quantify the genetic identity of individual cells profiled from multiple individuals concurrently. The findings have been published in Nature Methods.
-
Cancer stem cell morphology predicts glioblastoma growth and resistance
Human Technopole researchers have identified adducin-γ (ADD3) as a crucial regulator of glioblastoma cancer stem cell morphology and intercellular bridges between tumour cells. These connections facilitate communication and allow tumour cells to share resources, evade chemotherapy, and survive in challenging conditions. The study has been funded by AIRC and the findings are published in Life Science Alliance.
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.